Last reviewed · How we verify
TLI, TBI, ATG & Hematopoietic Stem Cell Transplantation and Recipient T Regs Therapy in Living Donor Kidney Transplantation
This study will determine whether a preparatory regimen including total lymphoid irradiation (TLI), total body irradiation (TBI), anti-thymocyte globulin (ATG) and infusion of the donor hematopoietic stem cells when given along with recipient regulatory T cells (Tregs) will allow for eventual discontinuation of anti-rejection drugs after living donor kidney transplantation.
Details
| Lead sponsor | Stanford University |
|---|---|
| Phase | PHASE1 |
| Status | UNKNOWN |
| Enrolment | 22 |
| Start date | Sat Feb 01 2020 00:00:00 GMT+0000 (Coordinated Universal Time) |
| Completion | Tue Oct 01 2024 00:00:00 GMT+0000 (Coordinated Universal Time) |
Conditions
- Living Donor Kidney Transplantation
Interventions
- Infusion of Donor Hematopoetic Stem Cells and Recipient Tregs
Countries
United States